Innovation Catalyst Ltd Company Profile

19:47 EDT 24th March 2018 | BioPortfolio

This year, we're launching an exciting new programme to help universities turn their latent intellectual property potential into the reality of market-ready companies.
To promote and explain this programme, we're completely re-writing our web site. In the meantime, if you'd like more information on turning your ideas' potential into reality


The Quadrus CentreWoodstock Way
Tyne & Wear
NE35 9PF
United Kingdom


Phone: 0044 (0)191 519 7284

News Articles [618 Associated News Articles listed on BioPortfolio]

Phase III Data Support Catalyst's NDA Resubmission For Firdapse

Catalyst executives note that the company has completed everything the FDA requested to support resubmission of Firdapse for its first...   

A catalyst for change

China’s plan to boost innovation and improve drug accessibility

Institute for Pediatric Innovation’s Program Addresses Pediatric Adverse Drug Events

The 2017-2018 Institute for Pediatric Innovation's (IPI) Clinical Innovation Catalyst Program focuses on Adverse Drug Events (ADEs). The Catalyst Program engages nurses and allied health professi...

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Catalyst eyes 2018 filing for rare disease drug candidate

Positive data from a second Phase 3 study has Catalyst on track to resubmit Firdapse for potential U.S. approval.

In The Spotlight: Catalyst Biosciences

Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

In The Spotlight: Catalyst Pharmaceuticals

Shares of Catalyst Pharmaceuticals Inc. (CPRX) are up an impressive 179% year-to-date while the iShares NASDAQ Biotechnology Index ETF (IBB) has gained just 17% during the same period.

PubMed Articles [666 Associated PubMed Articles listed on BioPortfolio]

The CNO and Leading Innovation: Competencies for the Future.

Although innovation is critical to success in today's tumultuous environment, health care is slow to embrace it, and there is significant variability in strategic adoption of innovation across organiz...

Young children's tool innovation across culture: Affordance visibility matters.

Young children typically demonstrate low rates of tool innovation. However, previous studies have limited children's performance by presenting tools with opaque affordances. In an attempt to scaffold ...

Government As Innovation Catalyst: Lessons From The Early Center For Medicare And Medicaid Innovation Models.

Congress established the Center for Medicare and Medicaid Innovation (CMMI) to design, test, and spread innovative payment and service delivery models that either reduce spending without reducing the ...

Network analysis of surgical innovation: Measuring value and the virality of diffusion in robotic surgery.

Existing surgical innovation frameworks suffer from a unifying limitation, their qualitative nature. A rigorous approach to measuring surgical innovation is needed that extends beyond detecting simply...

Accelerating Innovation Through Coopetition: The Innovation Learning Network Experience.

Coopetition, the simultaneous pursuit of cooperation and competition, is a growing force in the innovation landscape. For some organizations, the primary mode of innovation continues to be deeply secr...

Clinical Trials [113 Associated Clinical Trials listed on BioPortfolio]

Childhood Obesity Prevention Trough Education Innovation in Primary School: A Quasi-experimental Trial

This study evaluates the effect of the education innovation program"chiquichefs" on anthropometric variables, quality of life and nutritional habits in an elementary school children. Compa...

Satiety Innovation- Study 793. University of Aberdeen

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut heal...

SATIN: Satiety Innovation. Study 2- University of Aberdeen

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut heal...

Comparison of the New Fitting Method Cochlear Nucleus Fitting Software (NFS) With the Established Fitting Method Cochlear Nucleus Custom SoundTM Suite (CSS)

The purpose of this study is to evaluate if the new and simplified fitting method with Cochlear Nucleus Fitting Software (a major component of a suite of tools which form the Clinical Care...

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Companies [1024 Associated Companies listed on BioPortfolio]

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Catalyst Advisors, L.P.

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate cr...

Catalyst Investors

Catalyst Investors is a New York City-based growth equity firm focused on technology-enabled services including cloud computing, wireless infrastructure and digital media. Founded...

More Information about "Innovation Catalyst Ltd" on BioPortfolio

We have published hundreds of Innovation Catalyst Ltd news stories on BioPortfolio along with dozens of Innovation Catalyst Ltd Clinical Trials and PubMed Articles about Innovation Catalyst Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innovation Catalyst Ltd Companies in our database. You can also find out about relevant Innovation Catalyst Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record